Springer invited FSBI RCMG researcher as a Guest Editor

Springer publishing house invited FSBI RCMG researcher Lev N. Porokhovnik as a Guest Editor for Chromosome Research journal special issue on Ribosomal DNA: Experimental Models and Biomedical Applications. This is an international recognition of the RCMG researcher’s expertise in the field of rDNAomics. Chromosome Research (IF = 2.909) also published a review article in the Special Issue, the authors of which are FSBI RCMG researchers Lev N.Porokhovnik (Laboratory of Molecular Biology, chief – Ph.D. Svetlana V. Kostyuk) and Nataliya A. Lyapunova (Laboratory of Cytogenetics, chief – Ph.D. Nadezhda V. Shilova):

L.N. Porokhovnik, N.A. Lyapunova. Dosage effects of human ribosomal genes (rDNA) in health and disease. Chromosome Res (2019) 27:5-17

https://doi.org/10.1007/s10577-018-9587-y

Human ribosomal RNA genes encoding a pre-transcript of the three major ribosomal RNA (18S, 5.8S, and 28S rRNA) are tandemly repeated in human genome. Their total copy number varies from 250 to 670 per diploid genome with a mean of approximately 420 copies, but only a fraction of them is transcriptionally active. The functional consequences of human ribosomal RNA gene dosage are not widely known and often assumed to be negligible. Here, we review the facts of rRNA gene dosage effects on normal growth and aging, stress resistance of healthy individuals, and survivability of patients with chromosomal abnormalities, as well as on the risk and severity of some multifactorial diseases with proven genetic predisposition. An original hypothesis that rRNA gene dosage can be a modulating factor involved in the pathogenesis of schizophrenia and rheumatoid arthritis is put forward.

The Special Issue link: https://link.springer.com/journal/10577/27/1